Table 1 Demographic and clinical data of controlled and uncontrolled T2DM
Demographic characteristics | Total participants (n = 26) | Controlled T2DM (n = 7) | Uncontrolled T2DM (n = 19) | P value |
|---|---|---|---|---|
Male (%) | 16 (62.0%) | 4 (57.0%) | 12 (63.0%) | 0.8 |
Female (%) | 10 (37.0%) | 3 (43.0%) | 7 (37.0%) | 0.9 |
Mean age (SD)* | 66.1 (± 9.9) | 68.3 (± 9.7) | 65.3 (± 10.2) | 0.5 |
Clinical data | ||||
Overweight/obesity (%) | 15 (57.7%) | 3 (42.8%) | 12 (63.0%) | 0.5 |
Mean HbA1c (SD)** | 8.9 (± 2.4) | 6.3 (± 0.3) | 9.5 (± 2.3) | < 0.01 |
Mean BMI (SD)*** | 28.5 (± 4.8) | 27.9 (± 5.0) | 28.8 (± 4.8) | 0.7 |
Mean time since disease onset (SD)* | 18.7 (± 10.7) | 16.5 (± 9.2) | 19.5 (± 11.3) | 0.5 |
Dyslypidemia (%) | 10 (38.5%) | 2 (28.3%) | 8 (42.0%) | 0.7 |
Hypertension (%) | 18 (69.2%) | 7 (100%) | 11 (57.0%) | 0.04 |
Retinopathy (%) | 6 (23.0%) | 0 (0.0%) | 6 (31.6%) | – |
Neuropathy (%) | 13 (50.0%) | 2 (28.6%) | 11 (57.9%) | 0.4 |